600056 中国医药
2023/09 - 九个月
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
2019/12
人民币(K¥)
经营活动产生之现金流量净额(334,139)1,645,872148,4211,559,305(53,824)
投资活动产生之现金流量净额(227,669)22,139(254,455)(328,140)(3,106,256)
筹资活动产生之现金流量净额(502,766)(2,024)(729,189)(365,675)1,977,500
汇率变动对现金及现金等价物的影响3,13210,742(4,054)(9,976)5,320
现金及现金等价物净增加/(减少)(1,061,442)1,676,730(839,277)855,513(1,177,261)
期初现金及现金等价物余额3,511,0441,834,3142,673,5911,818,0782,995,339
期末现金及现金等价物余额2,449,6023,511,0441,834,3142,673,5911,818,078